Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4779014
Max Phase: Preclinical
Molecular Formula: C31H40N6O9
Molecular Weight: 640.69
Molecule Type: Unknown
Associated Items:
ID: ALA4779014
Max Phase: Preclinical
Molecular Formula: C31H40N6O9
Molecular Weight: 640.69
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCCC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC1=O
Standard InChI: InChI=1S/C31H40N6O9/c32-13-5-4-8-21-27(42)36-24(16-26(40)41)30(45)37-25(17-38)31(46)35-23(15-19-9-11-20(39)12-10-19)29(44)34-22(28(43)33-21)14-18-6-2-1-3-7-18/h1-3,6-7,9-12,21-25,38-39H,4-5,8,13-17,32H2,(H,33,43)(H,34,44)(H,35,46)(H,36,42)(H,37,45)(H,40,41)/t21-,22-,23-,24-,25-/m0/s1
Standard InChI Key: CTXUCRSDUQPHJN-KEOOTSPTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 640.69 | Molecular Weight (Monoisotopic): 640.2857 | AlogP: -1.79 | #Rotatable Bonds: 11 |
Polar Surface Area: 249.28 | Molecular Species: ZWITTERION | HBA: 9 | HBD: 9 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.93 | CX Basic pKa: 10.02 | CX LogP: -3.76 | CX LogD: -3.76 |
Aromatic Rings: 2 | Heavy Atoms: 46 | QED Weighted: 0.12 | Np Likeness Score: 0.75 |
1. Rahimi MN,Buckton LK,Zaiter SS,Kho J,Chan V,Guo A,Konesan J,Kwon S,Lam LKO,Lawler MF,Leong M,Moldovan GD,Neale DA,Thornton G,McAlpine SR. (2018) Synthesis and Structure-Activity Relationships of Inhibitors That Target the C-Terminal MEEVD on Heat Shock Protein 90., 9 (2): [PMID:30555625] [10.1021/acsmedchemlett.7b00310] |
Source(1):